Characterisation of a chronic pre-clinical model of allergic asthma

P. Flajolet (London, United Kingdom), J. De Alba (London, United Kingdom), K. Raemdonck (London, United Kingdom), M. Belvisi (London, United Kingdom), M. Birrell (London, United Kingdom)

Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Session: Studies on the mechanisms underlying airway disease
Session type: Thematic Poster
Number: 4413
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Flajolet (London, United Kingdom), J. De Alba (London, United Kingdom), K. Raemdonck (London, United Kingdom), M. Belvisi (London, United Kingdom), M. Birrell (London, United Kingdom). Characterisation of a chronic pre-clinical model of allergic asthma. 4413

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Development of an integrated allergic rhinitis and asthma model with partial immunological tolerance
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009

Characterization of CD4-endotypes in severe allergic asthma for future precision medicine
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001

Comparative analysis of allergic and non-allergic severe persistent asthma
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009


Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Grass pollen allergen induces asthma symptoms in a murine model of acute allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 587s
Year: 2005

Analysis of mucus production in mouse models of allergic asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010

Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007

Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008



Regular and moderate exercise prevents airway remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011

Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021


Clinical and experimental investigation of patients with allergic rhinitis and animal models
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008

Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008


Development of a novel prediction model for acute asthma exacerbation
Source: International Congress 2018 – Asthma management
Year: 2018

Small airways dysfunction: the link between allergic rhinitis and allergic asthma
Source: Eur Respir J, 51 (2) 1701749; 10.1183/13993003.01749-2017
Year: 2018



Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015